The GluN2B-C456Y mutation decreases recombinant NMDAR currents and alters receptor properties. by Wangyong Shin (6793040)

“…<p>(A) The GluN2B-C456Y mutation strongly decreases diheteromeric GluN1/GluN2B NMDAR currents in <i>Xenopus</i> oocytes. …”

VPS34 inhibition decreases intracellular levels of cholesteryl-esters, blocks cholesterol uptake and enhances lysosomal degradation of LDLR. by Marek J. Kobylarz (9292599)

FTY720 treatment decreased tumor growth in a xenograft model of hepatoblastoma. by Laura L. Stafman (6577184)

“…There was a trend toward decreased Ki67 staining in FTY720-treated tumors (p = 0.29). …”

TBC-2 is required for full lifespan extension and increased fat storage resulting from decreased insulin/IGF signaling. by İçten Meraş (13184380)

Data Sheet 2_Circulating prostaglandin E2 concentrations decrease at birth in premature lambs.docx by Timothy J. R. Panneflek (22702136)

“…Rationale<p>During pregnancy, prostaglandin E₂ (PGE₂) is released from the placenta and circulates in relatively high concentrations in the fetus. …”

Comparison of the decrease of CFU in CSF and blood between treatment groups within the first 6 h after treatment. by Luca G. Valente (12463057)

FTY720 decreased viability, proliferation, and motility and induced apoptosis in human hepatoblastoma cells. by Laura L. Stafman (6577184)

“…<p>(A) Following 24 hours of treatment with FTY720, the viability of HuH6 cells measured using the alamarBlue cell viability assay was significantly decreased (LD₅₀ = 8.4 μM, p ≤ 0.05). …”

Glutathione metabolism decreases during infection with <i>P</i>. <i>aeruginosa</i> in a FadE2-dependent manner. by Siraje Arif Mahmud (3188391)

Probability of release is decreased by hydrophobic mutations. by Matthew R. Bowers (8423115)

Multiple-step replication cycle of WT and rgC-A314G (K73R). by You-Yuan Tsai (3142086)

Subjects:

GSK343 decreased tumor stemness. by Laura V. Bownes (10276762)

“…Treatment with GSK343 significantly decreased tumorsphere formation by both the COA3 (A) and COA6 (B) cells, representing a decrease in stem cell-like phenotype. …”

Human cerebral organoids treated with VPA show a decreased size, impaired neurogenesis, and induction of senescence in NE cells. by Muriel Rhinn (406515)

E₅₀ values. by Junxia Zhou (14381598)

Data Sheet 1_Circulating prostaglandin E2 concentrations decrease at birth in premature lambs.docx by Timothy J. R. Panneflek (22702136)

“…Rationale<p>During pregnancy, prostaglandin E₂ (PGE₂) is released from the placenta and circulates in relatively high concentrations in the fetus. …”

NS affects lipid transport in ApoE^-/-mouse models. by Yihua Wang (491766)

<i>RTTN</i>-mutated organoids exhibit decreased proliferation and increased cell death at early stages. by Justine Guguin (9088672)

Host population bottlenecks decrease microbiome diversity. by Michael Ørsted (5926028)

Characteristics of patients with AKI diagnosed using eKDIGO only by the decrease in sCr (deKDIGO) and no AKI. by Marina Wainstein (12437091)

Rcan2-mediated decrease in intracellular K⁺ involves Kcnk5b. by Xiaowen Jiang (8291814)

Ppk1 levels are not affected by decreasing dendrite arbor size but are reduced when dendrite length increases. by Josephine W. Mitchell (17364781)